1. Home
  2. LXFR vs BCYC Comparison

LXFR vs BCYC Comparison

Compare LXFR & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$15.88

Market Cap

421.4M

Sector

Industrials

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.93

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXFR
BCYC
Founded
1898
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.4M
360.7M
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
LXFR
BCYC
Price
$15.88
$4.93
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
115.1K
396.0K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
3.65%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$384,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.01
N/A
P/E Ratio
$122.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.96
$4.24
52 Week High
$16.03
$9.36

Technical Indicators

Market Signals
Indicator
LXFR
BCYC
Relative Strength Index (RSI) 78.43 49.61
Support Level $11.55 $4.52
Resistance Level $16.00 $5.41
Average True Range (ATR) 0.53 0.23
MACD 0.29 0.02
Stochastic Oscillator 96.80 50.00

Price Performance

Historical Comparison
LXFR
BCYC

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: